Physician profile
Scott D Van Dam
NPI 1407836992
$5,834.56
in general payments reported to CMS, 2019-2025
9 companies · $41.71 in 2025
The $41.71 reported for 2025 was less than what a typical Oral & Maxillofacial Surgery provider received nationally (typical 2025 total: $184).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $377 · 2020: $74.94 · 2021: $79.85 · 2022: $4,273 · 2023: $815 · 2024: $172 · 2025: $41.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $600 · Food and Beverage: $429.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $600.00 |
| Food and Beverage | $429.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Ih INC. | $4,229.83 | 2019-2022 | |
| Dentsply LLC | $600.00 | 2023 | |
| Dentsply Sirona INC | $307.85 | 2019-2023 | Astra Tech Implant System |
| Zimvie INC. | $188.77 | 2022-2024 | |
| Biohorizons Implant Systems INC. | $184.41 | 2019-2025 | Biohorizons Dental Implants |
| Salvin Dental Specialties, INC. | $104.56 | 2019 | |
| Straumann USA LLC | $90.04 | 2023-2025 | |
| Kls-Martin L.P. | $69.80 | 2019 | |
| Zimmer Biomet Holdings, INC. | $59.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Van Dam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.